POSTER SESSION VI
Wednesday, March 5, 2008   —  1:00 PM - 4:00 PM
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GASTROINTESTINAL PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
31 Up-Regulation of the HIF-1 Transcriptional Pathway in Colorectal Carcinomas (541)
D Furlan, N Sahnane, R Cerutti, I Carnevali, S Uccella, V Bertolini, AM Chiaravalli, C Capella - University of Insubria, Varese, Italy; Ospedale di Circolo, Varese, Italy 		Add
32 HoxB13 Expression Predicts Increased Disease-Free Survival in Colorectal Carcinoma (538)
RL Fleshman, J Shia, D Notterman, P Paty, W Gerald, A Andea - The University of Alabama at Birmingham, Birmingham, AL; Memorial Sloan-Kettering Cancer Center, New York, NY 		Add
33 The Senescence Related Gene RSK4 Is Downregulated in Colon and Renal Cell Carcinomas and Induces Senescence When Overexpressed (569)
L López, G Armengol, M LLeonart, J Hernandez, S Landolfi, I de Torres, S Ramón y Cajal - Vall d'Hebron University Hospital, Barcelona, Spain 		Add
34 FISH for DCC Gene Deletion in Colorectal Cancer (592)
TT Nguyen, J Dolce, J Tan, M Detwiler, C Morrison - Roswell Park Cancer Institute, Buffalo, NY 		Add
35 Expression of Mineralocorticoid Receptor and 11b-Hydroxysteroid Dehydrogenase Type II in Stage II Colonic Cancer (642)
E Yakirevich, AC Laga, R Tavares, P Meitner, L Noble, E Sabo, DJ Morris, RA DeLellis, MB Resnick - Rhode Island Hospital and Brown Medical School, Providence, RI 		Add
36 Overexpression of SmgGDS in Colon Carcinoma (510)
DV Baewer, F Anwar, GA Dawson, Q Xiang, CL Williams, R Komorowski, R Li - Medical College of Wisconsin, Milwaukee, WI 		Add
37 CpG Island Methylator Phenotype, Loss of Heterozygosity and BRAF/KRAS Mutations in Microsatellite Stable Colorectal Cancer: Correlation with Clinicopathologic Features and Survival (561)
S Kakar, G Deng, H Tanaka, K Matsuzaki, YS Kim - VA and UCSF, San Francisco 		Add
38 Frequent CpG Methylation of Thrombospondin-1 in Colonic Adenomas and Adenocarcinomas (589)
M Naghashpour, AS Bedeir, J Di-Paola, Y Yao, R Day, AR Sepulveda - University of Pennsylvania, Philadelphia, PA; University of Pittsburgh, Pittsburgh, PA 		Add
39 Comparative Analysis of Three Different Panels for CpG Island Methylator Phenotype in Colorectal Cancer (564)
JH Kim, NY Cho, SY Park, S Lee, GH Kang - Seoul National University College of Medicine; Cancer Research Institute, Seoul National University; and Kyung Hee University College of Medicine, Seoul, Republic of Korea 		Add
40 BRAF (V600E) Mutation and Microsatellite Instability in Crohn's Disease Associated Adenocarcinoma (528)
JA Conklin, JA Lefferts, D-Y Park, C Siegel, M Mino-Kenudson, V Deshpande, BE Sands, GY Lauwers, GJ Tsongalis, A Srivastava - DHMC, Lebanon, NH; MGH, Boston, MA 		Add
41 miRNA Expression in Colorectal Carcinoma: Correlation with Microsatellite Instability (532)
JSL Earle, A Romans, R Abraham, A Rashid, S Hamilton, R Luthra - MD Anderson Cancer Center, Houston 		Add
42 Microsatellite Instability-High Colorectal Cancers in Korean Patients: Its Detection and Clinicopathologic Features (565)
 JM Kim, A Kim, WJ Sung, SH Suk, JH Kim, MC Shim, YK Bae - Yeungnam University College of Medicine, Daegu, Korea 		Add
43 Distinct CpG Island Methylation Profile and BRAF Mutation Status in Serrated and Adenomatous Colorectal Polyps (562)
S Kakar, YH Kim, G Deng, YS Kim - VA/UCSF Med Ctr, San Francisco 		Add
44 APC Mutation Frequency and Nuclear b-Catenin Expression in KRAS Mutated Conventional and Serrated Colorectal Adenomas (641)
H Xu, S Yang, B Burke, C Mack, S Cerda, C Shepherd, DW Rosenberg, D Pleau, MJ O'Brien - Boston University School of Medicine, Boston, MA; University of Connecticut Health Center, Farmington, CT 		Add
45 Molecular Features of Serrated Adenomas from Korea (568)
MK Kyoung, RD Odze - Samsung Medical Center, Seoul, Korea; Brigham and Women's Hospital, Boston, MA 		Add
46 Non-Gastrointestinal Pathologists Are Highly Reproducible in Their Diagnosis of Serrated Polyps of the Colorectum Following Tutorial Instruction (626)
MS Turner, HH Wang, MB Beasley, LC Collins, AL Folpe, JL Hecht, JL Hunt, M van de Rijn, JD Goldsmith - Beth Israel Deaconess Medical Center, Boston, MA; Cleveland Clinic Foundation, Cleveland, OH; Stanford School of Medicine, Stanford, CA; Mayo Clinic, Rochester, MN; Providence Portland Medical Center, Portland, OR 		Add
47 BD ProExC Immunostaining in Paget's Disease (630)
AE Walts, S Bose - Cedars-Sinai Medical Center, Los Angeles, CA 		Add
48 p16INK4a Is Surrogate Marker of High-Risk HPV in High-Grade Squamous Lesions and Invasive Carcinomas of the Anal Canal, but Not in Anal Condyloma (511)
R Balasubramaniam, CS Kong, J Erickson, N Pourmand, ML Welton, TA Longacre - Stanford University, Stanford, CA 		Add
49 Clinicopathologic Analysis of Large and Giant Condyloma Accuminata of the Anus (539)
TM Friedman, J Akinflorin, TS Tadros, D Altinel, M Tehrani, O Basturk, JV Little, M Tighiouart, NV Adsay - Emory University Hospital, Atlanta, GA; Wayne State University, Detroit, MI; NYU, New York, NY; Emory University School of Medicine, Atlanta, GA 		Add
50 Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma (514)
CC Black, RH Byrd, LE Fohn, AD Tatsas, MK Washington, JM Cates - Dartmouth Hitchcock Medical Center, Lebanon, NH; Vanderbilt University Medical Center, Nashville, TN 		Add
51 Tumor Expression of Integrin-Linked Kinase Correlates with the Expression of the E-Cadherin Repressor Snail: An Immunohistochemical Study in Ductal Pancreatic Adenocarcinoma (612)
DF Schaeffer, K Assi, K Chan, A Weiss, B Salh, DA Owen - University of British Columbia, Vancouver, BC, Canada 		Add
52 Sp1, a New Biomarker for Aggressive Pancreatic Ductal Adenocarcinoma (558)
NY Jiang, K Dresser, DI Lu - Massachusetts Institute of Technology, Boston, MA; University of Massachusetts, Worcester, MA 		Add
53 High Level of Nucleolin Expression Is Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma (597)
L Peng, J Liang, A Rashid, DB Evans, H Gomez, LJ Corley, JL Abbruzzese, SR Hamilton, H Wang - UT MD Anderson Cancer Center, Houston, TX; Pennsylvania State University, Hershey, PA 		Add
54 Is IgG4 Specific for Lymphoplasmacytic Sclerosing Pancreatitis and Similar Fibroinflammatory Lesions? (522)
TS Chen, RH Hruban, E Montgomery - The Johns Hopkins Medical Institutions, Baltimore, MD 		Add
55 Are Tumefactive Lesions Classified as Sclerosing Mesenteritis [Mesenteric Panniculitis, Mesenteric Lipodystrophy] a Subset of IgG4-Related Sclerosing Disorders? (521)
TS Chen, E Montgomery - Johns Hopkins, Baltimore 		Add
56 Gall Bladder Involvement in AIP Is a Primary Manifestation of the Disease (535)
AB Farris, W-L Wang, A Ganguly, GY Lauwers, V Deshpande - Massachusetts General Hospital, Boston, MA; University of Texas M.D. Anderson Cancer Center, Houston, TX 		Add
57 Distinct Pattern of Acetylation-Modified Histones in the Metaplasia - Dysplasia - Carcinoma Sequence of Gallbladder Carcinoma (533)
LJ Eisengart, M Zheng, J Laio, SM Rao, GY Yang - Northwestern University Feinberg School of Medicine, Chicago, IL 		Add
58 High Grade Transformation of Differentiated Neuroendocrine Neoplasms of the Enteropancreatic System - A Unique Entity Distinct from De Novo High Grade Neuroendocrine Carcinoma in Pathogenesis and Clinical Behavior (622)
LH Tang, J Shia, E Vakiani, D Dhall, DS Klimstra - Memorial Sloan-Kettering Cancer Center, New York, NY; Cedars-Sinai Medical Center, Los Angeles, CA 		Add
59 Immunohistochemical Phenotypes of Pancreatic Endocrine Neoplasms and Other Pancreatic Tumors That PENs Can Histologically Mimic (571)
KH Lee, HE Remotti - Columbia University Medical Center, New York, NY 		Add
60 Primary Leiomyosarcoma of the Pancreas: 9 Cases (647)
L Zhang, MH Jessen, TC Smyrk - Mayo Clinic, Rochester, MN 		Add